Indoxyl sulfate is a protein metabolite that is concentrated in the serum of patients with chronic renal insufficiency. It is also a uremic toxin that has been implicated in the progression of chronic renal disease in rodent models. We have previously shown that mesangial cell redox status is related to activation of mitogenactivated protein kinases and cell proliferation, which are factors related to glomerular damage. We used three methods to examine the ability of indoxyl sulfate to alter mesangial cell redox as a possible mechanism for its toxicity. Indoxyl sulfate increases mesangial cell reduction rate in a concentration-dependent manner as demonstrated by redox microphysiometry. Alterations occurred at concentrations as low as 100 µM, with more marked alterations occurring at higher concentrations associated with human renal failure. We demonstrated that indoxyl sulfate induces the production of intracellular reactive oxygen species (ROS) in mesangial cells (EC 50 = 550 µM) by using the ROS sensitive fluorescent dye CM-DCF. ROS generation was only partially ( 50%) inhibited by the NADPH oxidase inhibitor, diphenylene iodinium, at low ( 300 µM) indoxyl sulfate concentrations. Diphenylene iodinium was without effect at higher concentrations of indoxyl sulfate. We also used electron paramagnetic spin resonance spectroscopy with extracellular and intracellular spin traps to show that indoxyl sulfate increases extracellular, SOD-sensitive O 2
INTRODUCTION
End stage renal disease (ESRD) affects over 300,000 people in the U.S. at an annual cost of nearly $22 billion (41). One of the hallmarks of chronic renal insufficiency is the seemingly inexorable progression to end-stage renal disease. It is possible that accumulation of circulating toxins in chronic renal insufficiency could accelerate the progression to end stage renal disease. Substances which accumulate in patients with moderate to severe renal failure and which could mediate toxicity are collectively referred to as uremic toxins (30). In many forms of progressive renal disease, the renal mesangial cell serves as a key target for toxicity. The mesangial cell can respond to toxic stresses in several potentially deleterious ways, including proliferation, contraction, release of inflammatory mediators, and alterations in the glomerular basement membrane leading to irreversible fibrosis. Thus, it is possible that some of the manifestations of chronic renal diseases on the renal glomerulus might be due to the actions of uremic toxins on mesangial cells.
Indoxyl sulfate, which is also known as metabolic indican or urinary indican, is a naturally occurring metabolite of tryptophan. Because indoxyl sulfate levels are elevated in the serum of patients with chronic renal disease, it has been implicated as a putative uremic toxin. Indoxyl sulfate is produced in the liver by modification of indole, a tryptophan derivative that is generated by bacteria in the large intestine. Indoxyl sulfate levels are elevated in patients with chronic renal disease due to poor urinary clearance.
In addition, indoxyl sulfate has been shown to bind efficiently to albumin and therefore is not effectively cleared by hemodialysis (15, 38) .
Indoxyl sulfate and similar putative uremic toxins such as hippuric acid (HA), indole-3-carboxylic acid (IA) and 3-carboxy-4-methyl-5-propyl-2-furanpropanate (CMPF) have been shown to displace drugs from serum albumin (3, 5, 33, (37) (38) (39) , and more recently to act as substrates for organic anion transporters (Oat1 and Oat3) in proximal tubules (6, 7, 13, 14, 28, 34) , although the significance of those effects on progressive renal disease is not certain. Indoxyl sulfate and similar compounds are only now being recognized for their potential pathological role in cell signaling such as the production of reactive oxygen species (ROS), stimulation of proliferation, or alterations in extracellular matrix. Both ROS-mediated cell proliferation and oxidative stress in renal glomeruli can lead to glomerular hypertrophy, glomerulosclerosis, diminished renal function and eventually to chronic renal failure (18) . For uremic toxins such as indoxyl sulfate, one might envision a vicious cycle in which deteriorating renal function and reduced glomerular filtration contribute to progressive elevations of serum levels of indoxyl sulfate. In turn, indoxyl sulfate causes additional proliferative and fibrotic glomerular damage (30). Thus, it would be worthwhile to better understand the effects of indoxyl sulfate on native glomerular cells such as mesangial cells.
We (23, 24) , and others (20-22, 25, 27) , have previously demonstrated a role for the generation of ROS in mesangial cell proliferation and activation of mitogenic kinase cascades. In this study, we used three methods to establish that indoxyl sulfate, at concentrations (26, 31) found in serum of patients with ESRD (100-300 µM), can induce the complex production of reactive oxygen species in rat mesangial cells in culture.
Specifically, we wanted to address the role that NADPH oxidase may play in the production of ROS that are generated, since superoxide production via NADPH oxidase has been implicated in numerous redox signaling pathways (19) (20) (21) (22) 27 ). ROS might also play key roles in the signaling effects of indoxyl sulfate, and other uremic toxins.
EXPERIMENTAL PROCEDURES

Materials.
RPMI 1640 media, penicillin/streptomycin, phosphate buffered saline, Hanks Balanced Salt solution, and fetal calf serum were obtained from Cell culture. Primary rat renal mesangial cells were obtained from cortical sections of kidneys from young (100-to 150-g) male Sprague-Dawley rats using standard sieving techniques as described previously (24) . The kidneys were harvested in accordance with a protocol reviewed and approved by the Institutional Animal Care and Use Committee of the Medical University of South Carolina. Cells were incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 and were subcultured every 1-2 weeks by trypsinization until pure cultures of mesangial cells were obtained. These cells were plated at a density of 2-5 x 10 4 cells/ml in RPMI medium supplemented with 20% heat-inactivated fetal bovine serum and antibiotics (100 units/ml penicillin and 100 µg/ml streptomycin). Cells used were from passages 6-16. Therefore, we carried out our experiments in the absence of an exogenous mediator.
Once loaded, the chambers were maintained at 37° C and perfused with redox medium. The microphysiometer was calibrated to zero volts during perfusion.
Measurements were made during perfusion with redox medium, following which experimental measurements made by switching to medium containing test compounds. For FLIPR™ experiments, cells were seeded in 96-well plates, loaded with CM-DCFH 2 , and washed as described above. Plates were placed in the FLIPR instrument and equilibrated to 37 °C. The rate and extent of ROS production was measured by the increase of fluorescence of the oxidized dye. Measurements were taken every 1.5 seconds for 180 seconds and every 30 seconds up to 900 seconds, and the rate of ROS production was determined either as the function (slope) of total fluorescence versus time over the first 180 seconds, or as the maximum value obtained during the first 180 seconds or over the entire data acquisition period (900 seconds).
RESULTS
Indoxyl sulfate alters reducing rates in rat renal mesangial cells.
Redox induce ROS production in mesangial cells (23, 24) , increased the reducing rate Because indoxyl sulfate has been shown to bind avidly to albumin in human serum (3), we were concerned that albumin might interfere with the cellular actions of indoxyl sulfate. Figure 1C demonstrates that the addition of 0.5% bovine serum albumin to the perfusate does not alter the ability of indoxyl sulfate to increase the reducing rate at a pathophysiological concentration (500 µM). Similar results were obtained at higher concentrations (not shown). Thus, the presence of albumin is serum is unlikely to affect the ability of indoxyl sulfate, in concentrations demonstrated to occur in patients with end stage renal disease (15, 38) , to alter mesangial cell redox status. NADPH oxidase has previously been shown to be a major source of mesangial cell ROS (23, 24) . NADPH oxidase could be involved in the production of H 2 O 2 , as superoxide can be converted into H 2 O 2 through the actions of superoxide dismutase.
Indoxyl sulfate induces ROS formation in rat mesangial
To examine a potential role for NADPH oxidase in the effects of indoxyl sulfate, we pretreated mesangial cells with medium containing either 100 µM DPI, 300 µM apocyanin, or vehicle (DMSO) during CM-DCFH 2 loading, following which we exposed cells to increasing indoxyl sulfate concentrations. After pretreatment, the cells were Figure 4B) , although there remained a residual signal at 10 minutes following exposure ( Figure 4G ).
Indoxyl sulfate increases extracellular ROS production in rat mesangial cells.
Electron paramagnetic resonance (EPR) spectroscopy is a useful tool for measuring ROS production because it directly probes free radicals, and can be used both to quantitate and to identify specific free radical species. We used an O 2 •-selective spin Figure 7C shows the EPR spectrum for control cells pretreated with EMPO, washed and then exposed to buffer. Computer simulation of the spectrum observed in Figure 7A with WinSim2000 (12) can be used to identify the radical species trapped, because the spectral parameters are unique for each type of EMPO-trapped radical. Simulation of the spectrum was best fit using the parameters listed in Table 1 , which are consistent with those obtained from spectra of EMPO-OH • (35, 40) . The simulated spectrum is shown in 
DISCUSSION
The role of indoxyl sulfate as an uremic toxin is not completely understood, but it has been shown to inhibit binding of drugs to serum albumin (37, 38); to be elevated in sera of ESRD patients (100-300 µM vs. 0-3 µM in normal patients) and in animal models of renal disease (31, 32) ; to cause progression of renal disease in rats (1, 2, 32); and to be a substrate for, and an inhibitor of, human organic anion transporters in proximal tubules (6, 7, 13, 14) . Recently, indoxyl sulfate has been implicated in increased carbonyl stress in hemodialysis patients (26) . We have previously shown that there is a relationship between altered redox status and activation of mitogenic kinases and production of the profibrotic factor, TGF-, in mesangial cells (4, 23, 24) . The purpose of this study was to identify a potential role for indoxyl sulfate as a mediator of oxidative stress in mesangial cells.
What is new about this work is that we have used three methods to demonstrate that indoxyl sulfate, when applied at concentrations seen in patients with chronic renal insufficiency, rapidly induces the production of intracellular and extracellular ROS in cultured mesangial cells. We previously used redox microphysiometry to demonstrate that hormones can alter the redox states of various cell lines including mesangial cells (24) and transfected fibroblasts (29). In the current study, increasing concentrations of indoxyl sulfate (up to 1 mM) resulted in an increased reducing rate (an indicator of ROS production) to a maximum of 250% of basal levels. When mesangial cells were exposed to concentrations of indoxyl sulfate similar to those that are manifested in patients with end stage renal disease (100-300 µM), the reducing rate was increased to 150% of basal levels. Redox microphysiometry can be used to detect ROS that are produced extracellularly, or those produced intracellularly and transported to the extracellular space. Although redox microphysiometry can serve as a screening tool for cellular redox effects on cells, it does not provide significant insight into the nature of the ROS being produced. Accordingly, we used two different methods to examine intracellular and extracellular ROS formation in response to indoxyl sulfate. We used the fluorescent dye, CM-DCFH 2 , to measure selective intracellular H 2 O 2 production, and EPR spin trapping to identify both intracellular and extracellular ROS. Studies with CM-DCFH 2 showed that indoxyl sulfate increased H 2 O 2 production, and at concentrations of indoxyl sulfate 300 µM, this effect was sensitive to DPI and apocyanin ( Figures 3 and 4) , suggesting that NADPH oxidase was involved in the process. This is plausible in that O 2 •-(the product of NADPH oxidase) can be converted to H 2 O 2 by superoxide dismutase.
Nevertheless, there was a significant DPI-insensitive component of H 2 O 2 production that became predominant at indoxyl sulfate concentrations > 300 µM, suggesting that indoxyl sulfate induces production of H 2 O 2 in mesangial cells through two pathways.
The relevance of this high concentration of indoxyl sulfate effect in light of the known pathophysiological levels of the uremic toxin, can be debated, but it is possible that these high concentrations could exist, however fleetingly, in localized intercellular space in the compromised nephron.
We also found that indoxyl sulfate could induce the production of intracellular hydroxyl radical (HO B is a simulation of the spectrum in A using the parameters listed in Table 1 . EPR spectra A and C are representative of experiments that were carried out at least 3 times. 
